S-equol ingredient for women’s wellness For brands & formulation teams

EQUOPRO® / SCIENCE & INNOVATION

Research, in perspective.
Evidence you can explore.

Explore the human research, read the original publication and follow the status of our research pipeline.

Research overview · Updated

The published paper and completed trial describe the same study, not two independent clinical studies. Patent and review counts are supplied by Shanghai EGT Synbio; individual records are awaiting public documentation.

01 / HUMAN RESEARCH

A completed exploratory study.

Published · 3 September 2026

S-equol in perimenopausal women

An eight-week exploratory, randomized, double-blind, placebo-controlled trial. Thirty women enrolled; 27 completed the study.

Findings are preliminary. Small sample size, baseline imbalance, completer analysis and unadjusted multiple comparisons limit interpretation.

Explore the study & results ↗
Study duration
8 weeks
Participants
30 enrolled · 27 completed
Study dose
10 mg/day
Interpretation
Exploratory findings
Study context
The dose describes the research protocol, not a consumer intake recommendation.

02 / PUBLICATIONS

Read the original research.

Published clinical paper

Effects Of 10 Mg S-Equol on Menopausal Symptoms and Skin Health in Perimenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Trial

Zhang W, Li Y · American Journal of Biomedical Science & Research · 2026;32(1)

DOI: 10.34297/AJBSR.2026.32.004130. This publication reports the clinical study above.

Read original PDF ↗

REVIEW MANUSCRIPTS / PUBLICATION PENDING

Two reviews in the research pipeline.

Shanghai EGT Synbio reports two review manuscripts awaiting publication. Titles, authors, journal details and publication dates have not yet been provided for this site.

These are not listed as published or accepted papers. Individual entries will be added when citation details are available.

Ask for publication updates →

03 / PATENT APPLICATIONS

Innovation, with status made clear.

Three patent applications reported by the supplier.

Application titles, numbers, jurisdictions and current prosecution status have not yet been provided for this site. The count refers to applications, not granted patents.

Patent applications do not establish clinical efficacy or regulatory approval.

Request patent application details →

CONTINUE YOUR EVALUATION

Connect the evidence to the ingredient.

Review identity, specifications and supporting quality documents alongside the research.

View specifications ↗